"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Descriptor ID |
D010300
|
MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 0 | 5 |
1995 | 4 | 0 | 4 |
1996 | 6 | 1 | 7 |
1997 | 7 | 0 | 7 |
1998 | 13 | 0 | 13 |
1999 | 12 | 2 | 14 |
2000 | 17 | 1 | 18 |
2001 | 9 | 1 | 10 |
2002 | 17 | 1 | 18 |
2003 | 28 | 0 | 28 |
2004 | 14 | 0 | 14 |
2005 | 14 | 3 | 17 |
2006 | 22 | 3 | 25 |
2007 | 27 | 3 | 30 |
2008 | 26 | 1 | 27 |
2009 | 27 | 6 | 33 |
2010 | 27 | 2 | 29 |
2011 | 34 | 1 | 35 |
2012 | 17 | 3 | 20 |
2013 | 35 | 5 | 40 |
2014 | 33 | 1 | 34 |
2015 | 23 | 2 | 25 |
2016 | 34 | 5 | 39 |
2017 | 36 | 2 | 38 |
2018 | 34 | 3 | 37 |
2019 | 23 | 4 | 27 |
2020 | 39 | 3 | 42 |
2021 | 27 | 3 | 30 |
2022 | 31 | 1 | 32 |
2023 | 25 | 0 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants. Mov Disord. 2023 Dec; 38(12):2155-2162.
-
Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review. Appl Nurs Res. 2023 12; 74:151745.
-
Device-aided therapies for Parkinson's disease: "All for one, one for all, that is our device". Parkinsonism Relat Disord. 2023 Nov; 116:105862.
-
Mortality in Women across the FMR1 CGG Repeat Range: The Neuroprotective Effect of Higher Education. Cells. 2023 08 24; 12(17).
-
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. Lancet Neurol. 2023 11; 22(11):1015-1025.
-
Overview of the Gut-Brain Axis: From Gut to Brain and Back Again. Semin Neurol. 2023 08; 43(4):506-517.
-
Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10?Years CERE120 Delivery. Mov Disord. 2023 09; 38(9):1728-1736.
-
Reply to: Comment on "Summing MDS-UPDRS Parts 1?+?2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice". Mov Disord. 2023 08; 38(8):1564.
-
Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults. Neurology. 2023 08 15; 101(7):e754-e763.
-
Genetic Testing in Parkinson's Disease. Mov Disord. 2023 08; 38(8):1384-1396.